Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure

FEMS Microbiology Letters

Volumn 364, Issue 6, 2017, Pages

  Cresci, Gail A M ^a   Mayor, Paul C ^b   Thompson, Stuart A ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Butyrate; Caco 2; Campylobacter jejuni; Lactobacillus GG

Indexed keywords

BUTYRIC ACID; CARRIER PROTEINS AND BINDING PROTEINS; PROBIOTIC AGENT; PROTEIN HCAR2; PROTEIN SLC5A8; RECEPTOR; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; CARRIER PROTEIN; G PROTEIN COUPLED RECEPTOR; HCAR2 PROTEIN, HUMAN; MONOCARBOXYLATE TRANSPORTER; NICOTINIC RECEPTOR; SLC5A8 PROTEIN, HUMAN;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CACO-2 CELL LINE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; LACTOBACILLUS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES INVASION; CAMPYLOBACTERIOSIS; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; LACTOBACILLUS RHAMNOSUS; METABOLISM; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY;

BACTERIAL ADHESION; BUTYRATES; CACO-2 CELLS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CARRIER PROTEINS; CELLS, CULTURED; GENE EXPRESSION; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS RHAMNOSUS; MICROBIAL INTERACTIONS; MONOCARBOXYLIC ACID TRANSPORTERS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NICOTINIC;

EID: 85019909727     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1093/femsle/fnx046     Document Type: Article

References (32)

1. Alvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on traditional therapy. Clin Infect Dis 2001;32:1567-76.
2. Bhavsar SP, Kapadnis BP. Virulence factors of Campylobacter. Internet J Microbiol 2007;3:1-7.
3. Bianchi MA, Del Rio D, Pellegrini N et al. A fluorescence-based method for the detection of adhesive properties of lactic acid bacteria to Caco-2 cells. Lett Appl Microbiol 2004;39:301-5.
4. Black RE, Levine MM, Clements ML et al. Experimental Campylobacter jejuni infection in humans. J Infect Dis 1988;157: 472-9.
5. Borthakur A, Priyamyada S, Kumar A et al. A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1. Am J Physiol Gastr L 2012;303:G1126-33.
6. Center for Disease Control. Foodborne Germs and Illnesses. http://www.cdc.gov/foodsafety/foodborne-germs.html (date last accessed, 4 November 2016).
7. Cook S, Sellin J. Review article: short chain fatty acids in health and disease. Aliment Pharmocol Ther 1998;12:499-507.
8. Cresci G, Nagy LE, Ganapathy V. Lactobacillus GG and tributyrin supplementation reduce antibiotic-induced intestinal injury. JPEN-Parenter Enter 2013;37:763-74.
9. Cresci GA, Thangaraju M, Mellinger JD et al. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8. J Gastrointest Surg 2010;14:449-61.
10. D'Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta 2015;451:97-102.
11. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 2003;111:931-43.
12. Food and Agriculture Organization and World Health Organization. Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada: Food and Agriculture Organization and World Health Organization, 2001. http://who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf (date last accessed, 27 September 2016).
13. kB activation. MediatIn- flamm 2014;2014:983-401.
14. Goldin BR, Gorback SL, Saxelin M et al. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 1992;37:121-8.
15. Grimm V, Riedel CU. Manipulation of the microbiota using probiotics. Adv Exp Med Biol 2016;902:109-17.
16. Gueimonde M, Jalonen L, He F et al. Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Res Int 2006;39:467-71.
17. Kaakoush NO, Castaño-Rodríguez N, Mitchell HM et al. Global epidemiology of Campylobacter. Infect Clin Microbiol Rev 2015;28:687-720.
18. Lehto EM, Salminen SJ. Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS Immunol Med Micr 1997;18:125-32.
19. Minamino T, Imae Y, Oosawa F et al. Effect of intracellular pH on rotational speed of bacterial flagellar motors. J Bacteriol 2003;185:1190-4.
20. Mufandaedza J, Viljoen BC, Fersu SB et al. Antimicrobial properties of lactic acid bacteria and yeast-LAB cultures isolated form traditional fermented milk against pathogenic Escherichia coli and Salmonella enteritidis strains. Intern J Food Microbiol 2006;108:147-52.
21. NIAID Emerging Infectious Diseases/Pathogens. National Institute of Allergy and Infectious Diseases https://www.niaid.nih.gov/research/emerging-infectious-diseases- pathogens (date last accessed, 17 October 2016).
22. Pajaniappan M, Hall JE, Cawthaw SA et al. A temperature- regulated Campylobacter jejuni gluconate dehydrogenase is involved in respiration-dependent energy conservation and chicken colonization. Mol Microbiol 2008; 68:474-91.
23. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Cl Ga 2003;17:741-54.
24. Shanahan F. Probiotics in perspective. Gastroenterology 2010;139:1808-12.
25. Singh N, Gurav A, Sivaprakasam S et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014;40:128-39.
26. Siavoshian S, Segain JP, Kornprobst M et al. Butyrate and tricho- statin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 2000;46:507-14.
27. Thangaraju M, Cresci G, Anath S et al. GPR109A is a G-protein- coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 2009;69:2826-32.
28. Thangaraju M, Cresci G, Itagaki S et al. Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer. J Gastrointest Surg 2008; 2:1773-81.
29. Tuomola EM, Salminen SJ. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol 1998;41:45-51.
30. Van Deun K, Pasmans F, Van Immerseel F et al. Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation. Br J Nutr 2008;100:480-4.
31. Wise A, Foord SM, Fraser JN et al. Molecular identification of high and low affinity receptors for nicotinic acid. J Biol Chem 2003;278:9869-74.
32. World Health Organization (WHO). Campylobacter Fact Sheet. http://www.who.int/mediacentre/factsheets/fs255/en/ (date last accessed, 17 October 2016).